Clinverse, Inc., a technology company focused on the financial management of clinical trials and associated payments in over 140 currencies, has announced it has completed a $2.2m Series A financing round.
In conjunction with the funding, Craig Asher joined the company’s board.
Charlotte, NC-based Clinverse also announced that Umair Akeel has joined the company as its Chief Technology Officer (CTO).
The investment syndicate comprised current investors and Vital Financial, LLC.
As stated by Tim Immel, Clinverse’s Chairman and CEO, the capital will allow the company to accelerate ClinPay, a eClinical Trial Payment Network.